Objective
Adipose tissue (AT), in contrast to skeletal muscle, accounts for a small part of the insulin-stimulated glucose disposal. Skeletal muscle has been the focus of most research to define mechanisms for peripheral insulin resistance (IR), adipose tissue has long been neglected. However, studies have shown that AT not only stores and releases energy as lipids, it is also the largest endocrine organ. Several factors secreted by AT, such as free fatty acids and adipokines, have been shown to affect insulin sensitivity not only in AT but also in other tissues. These factors are altered in IR states and they are likely to play an important role in the development of congestive heart failure (CHF). Excess of AT increases the risk of a number of conditions including coronary artery disease and diabetes. We will study the molecular mechanisms of IR and inflammation, focusing on the function of the adipocyte in CHF. Recent work tried to correlate changes in several cytokines with the progression and poor prognosis of CH F. However, little is known about the impact of adipose tissue in this condition, we aim at clarifying the relationships between CHF, IR, diabetes, its drug therapy and cytokine levels. We will try to understand if signalling pathways utilized by insulin and inflammatory mediators, in normal and IR states, are different or if they are the same. In addition, we want to elucidate the effects of immunosuppressive agents (IA) administration on IR and the action of insulin in cultured cells and rodents and study the role of adipocytes in this condition. IA may play a role in the development of IR, but the precise mechanisms are not well understood. It maybe that IA administration causes imbalances in systemic glucose and lipid metabolism at the level of the adipocyte. IR maybe an impaired ability to store fat in AT which in turn leads to lipid accumulation in liver and skeletal muscle and this dysregulation maybe associated with abnormal expression of cytokines.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine endocrinology diabetes
- natural sciences biological sciences biochemistry biomolecules lipids
- medical and health sciences clinical medicine cardiology
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2004-MOBILITY-12
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
IRG - Marie Curie actions-International re-integration grants
Coordinator
Portugal
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.